IT1246445B - Composizioni farmaceutiche con migliorate proprieta' di dissoluzione. - Google Patents

Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.

Info

Publication number
IT1246445B
IT1246445B IT02137090A IT2137090A IT1246445B IT 1246445 B IT1246445 B IT 1246445B IT 02137090 A IT02137090 A IT 02137090A IT 2137090 A IT2137090 A IT 2137090A IT 1246445 B IT1246445 B IT 1246445B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
dissolution properties
improved dissolution
improved
properties
Prior art date
Application number
IT02137090A
Other languages
English (en)
Other versions
IT9021370A1 (it
IT9021370A0 (it
Inventor
Alessandro Martini
Clara Torricelli
Carlo Confalonieri
Ponti Roberto De
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IT9021370A0 publication Critical patent/IT9021370A0/it
Publication of IT9021370A1 publication Critical patent/IT9021370A1/it
Application granted granted Critical
Publication of IT1246445B publication Critical patent/IT1246445B/it

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT02137090A 1989-09-06 1990-09-04 Composizioni farmaceutiche con migliorate proprieta' di dissoluzione. IT1246445B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898920135A GB8920135D0 (en) 1989-09-06 1989-09-06 Use of dehydrated cyclodextrins for improving drug dissolution

Publications (3)

Publication Number Publication Date
IT9021370A0 IT9021370A0 (it) 1990-09-04
IT9021370A1 IT9021370A1 (it) 1992-03-04
IT1246445B true IT1246445B (it) 1994-11-18

Family

ID=10662618

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02137090A IT1246445B (it) 1989-09-06 1990-09-04 Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.

Country Status (5)

Country Link
US (1) US5126333A (it)
JP (1) JP2948886B2 (it)
DE (1) DE4028004A1 (it)
GB (2) GB8920135D0 (it)
IT (1) IT1246445B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
HU213200B (en) * 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
CA2167362A1 (en) * 1995-02-10 1996-08-11 Alexei Dmitri Klimov Apparatus and method for conducting a binding assay on an absorbent carrier material
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
JP4504678B2 (ja) * 2001-08-15 2010-07-14 セルレジン テクノロジーズ，エルエルシー 改善された遮断性を備えた包装材料
BRPI0105509B8 (pt) * 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
PL2708225T3 (pl) * 2004-04-23 2019-07-31 Cydex Pharmaceuticals, Inc. Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
JP5830412B2 (ja) * 2011-03-02 2015-12-09 ライオン株式会社 水難溶性薬物と賦形剤との粉砕物の製造方法、造粒粒子の製造方法、錠剤の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5661369A (en) * 1979-10-26 1981-05-26 Iwaki Seiyaku Kk Inclusion compound of thialamide or its acid addition salt
DE3481887D1 (de) * 1983-09-29 1990-05-10 Nippon Telegraph & Telephone Funkempfangssystem fuer ein phasenmoduliertes signal.
JPS6121184A (ja) * 1984-07-10 1986-01-29 Mitsubishi Electric Corp 水溶性酸化防止剤の製造方法
SU1357410A1 (ru) * 1985-01-24 1987-12-07 Предприятие П/Я Р-6710 Способ получени соединений включени @ -циклодекстрина и инертных газов
JPS62267261A (ja) * 1986-05-14 1987-11-19 Ichimaru Pharcos Co Ltd β−カロチン包接物
JPH0764884B2 (ja) * 1986-11-27 1995-07-12 株式会社トクヤマ シクロデキストリン組成物

Also Published As

Publication number Publication date
GB2236252A (en) 1991-04-03
GB9019236D0 (en) 1990-10-17
IT9021370A1 (it) 1992-03-04
US5126333A (en) 1992-06-30
DE4028004A1 (de) 1991-03-07
GB8920135D0 (en) 1989-10-18
JPH0393732A (ja) 1991-04-18
GB2236252B (en) 1993-03-17
JP2948886B2 (ja) 1999-09-13
IT9021370A0 (it) 1990-09-04

Similar Documents

Publication Publication Date Title
FI922364L (fi) Farmaceutiska kompositioner.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI943569A7 (fi) Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia
FI923582L (fi) Farmaceutisk sferoidkomposition
IT8920486A0 (it) Composizioni farmaceutiche.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
IT9022032A0 (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FR2654223B1 (fr) Protection d'objectif.
DK0426806T3 (da) Polymersammensætninger
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643L (fi) Farmaceutiska kompositioner.
IT9021370A0 (it) Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.
DE69007908D1 (de) Shampoo-Zusammensetzung.
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
DE69012664D1 (de) Kältezusammensetzungen.
FI883673A7 (fi) Farmaceutiska kompositioner.
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
DE69013711D1 (de) Polymerzusammensetzung.
NO933506D0 (no) Ioderte fuktemidler
MA21272A1 (fr) Derives d'oximino ethers.
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
IT219116Z2 (it) "siringa di sicurezza"
FR2654123B1 (fr) Solution d'agent de blanchiment fluorescent.
MA21961A1 (fr) Compositions fumigastriques eppaissies .

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970929